PMID- 20971965 OWN - NLM STAT- MEDLINE DCOM- 20110225 LR - 20211020 IS - 1939-327X (Electronic) IS - 0012-1797 (Print) IS - 0012-1797 (Linking) VI - 60 IP - 1 DP - 2011 Jan TI - P-selectin glycoprotein ligand-1 deficiency is protective against obesity-related insulin resistance. PG - 189-99 LID - 10.2337/db09-1894 [doi] AB - OBJECTIVE: An inflammatory process is involved in the mechanism of obesity-related insulin resistance. Recent studies indicate that monocyte chemoattractant protein-1 (MCP-1) is a major chemokine that promotes monocyte infiltration into adipose tissues; however, the adhesion pathway in adipose tissues remains unclear. We aimed to clarify the adhesion molecules that mediate monocyte infiltration into adipose tissue. RESEARCH DESIGN AND METHODS: We used a DNA microarray to compare the gene expression profiles in epididymal white adipose tissues (eWAT) between db/db mice and C57/BL6 mice each fed a high-fat diet (HFD) or a low-fat diet (LFD). We investigated the change of insulin resistance and inflammation in eWAT in P-selectin glycoprotein ligand-1 (PSGL-1) homozygous knockout (PSGL-1(-)(/)(-)) mice compared with wild-type (WT) mice fed HFD. RESULTS: DNA microarray analysis revealed that PSGL-1, a major ligand for selectins, is upregulated in eWAT from both db/db mice and WT mice fed HFD. Quantitative real-time RT-PCR and immunohistochemistry showed that PSGL-1 is expressed on both endothelial cells and macrophages in eWAT of obese mice. PSGL-1(-)(/)(-) mice fed HFD showed a remarkable reduction of macrophage accumulation and expression of proinflammatory genes, including MCP-1 in eWAT. Moreover, adipocyte hypertrophy, insulin resistance, lipid metabolism, and hepatic fatty change were improved in PSGL-1(-)(/) (-)mice compared with WT mice fed HFD. CONCLUSIONS: These results indicate that PSGL-1 is a crucial adhesion molecule for the recruitment of monocytes into adipose tissues in obese mice, making it a candidate for a novel therapeutic target for the prevention of obesity-related insulin resistance. FAU - Sato, Chikage AU - Sato C AD - Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Japan. FAU - Shikata, Kenichi AU - Shikata K FAU - Hirota, Daisho AU - Hirota D FAU - Sasaki, Motofumi AU - Sasaki M FAU - Nishishita, Shingo AU - Nishishita S FAU - Miyamoto, Satoshi AU - Miyamoto S FAU - Kodera, Ryo AU - Kodera R FAU - Ogawa, Daisuke AU - Ogawa D FAU - Tone, Atsuhito AU - Tone A FAU - Kataoka, Hitomi Usui AU - Kataoka HU FAU - Wada, Jun AU - Wada J FAU - Kajitani, Nobuo AU - Kajitani N FAU - Makino, Hirofumi AU - Makino H LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20101022 PL - United States TA - Diabetes JT - Diabetes JID - 0372763 RN - 0 (DNA Primers) RN - 0 (E-Selectin) RN - 0 (Insulin) RN - 0 (Membrane Glycoproteins) RN - 0 (P-Selectin) RN - 0 (P-selectin ligand protein) SB - IM MH - Adipocytes/physiology MH - Animals MH - DNA Primers MH - Diet, Fat-Restricted MH - E-Selectin/genetics MH - Fatty Liver/prevention & control MH - Flow Cytometry MH - Gene Expression Profiling MH - Glucose Tolerance Test MH - Humans MH - Inflammation/genetics/physiopathology MH - Insulin/pharmacology MH - Insulin Resistance/genetics/*physiology MH - Membrane Glycoproteins/*deficiency/genetics MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Obesity/genetics/*prevention & control MH - Oligonucleotide Array Sequence Analysis MH - P-Selectin/genetics MH - Phosphorylation MH - Reverse Transcriptase Polymerase Chain Reaction MH - Up-Regulation PMC - PMC3012171 EDAT- 2010/10/26 06:00 MHDA- 2011/02/26 06:00 PMCR- 2012/01/01 CRDT- 2010/10/26 06:00 PHST- 2010/10/26 06:00 [entrez] PHST- 2010/10/26 06:00 [pubmed] PHST- 2011/02/26 06:00 [medline] PHST- 2012/01/01 00:00 [pmc-release] AID - db09-1894 [pii] AID - 1894 [pii] AID - 10.2337/db09-1894 [doi] PST - ppublish SO - Diabetes. 2011 Jan;60(1):189-99. doi: 10.2337/db09-1894. Epub 2010 Oct 22.